Your Everyday Provider: The Role of Oncology Nurses

May 14, 2025, at 12 p.m. EST

Rose Gerber, MS, Advocacy Chat host and COA’s Director of Patient Advocacy and Education, will be joined by Shannon Besselman, RN, BSN, a clinical manager for Northwest Medical Specialties for a discussion of the roles that oncology nurses play in community oncology practices.

Previous Advocacy Chats

Each month, a special guest joins COA’s Director of Patient Advocacy & Education, Rose Gerber for a conversation on oncology and advocacy-related topics.

A prepared advocate is an effective advocate. That’s why COA and CPAN are working to provide advocates with the latest information on policy changes. As a new year begins, ensure you have the tools and knowledge you need to advocate for local, affordable cancer care.

View all past chats with full video playback, notes, and session slides.

Previous Advocacy Chats

Each month, a special guest joins COA’s Director of Patient Advocacy & Education, Rose Gerber for a conversation on oncology and advocacy-related topics.

A prepared advocate is an effective advocate. That’s why COA and CPAN are working to provide advocates with the latest information on policy changes. As a new year begins, ensure you have the tools and knowledge you need to advocate for local, affordable cancer care.

View all past chats with full video playback, notes, and session slides.

  • The COA Policy and Advocacy Mid-Year Update

    July 12, 2023 12:00 pm

    We took stock of the policy landscape for the July 2023 Advocacy Chat – advocates joined the Community Oncology Alliance Patient Advocacy Network (CPAN) on Wednesday, July 12 at 12 p.m. ET to learn about the major cancer policy events from the first half of the year, what bills and projects are in the works, and COA’s plans for the second half of 2023. COA’s Managing Director Nicolas Ferreyros and Director of Patient Advocacy and Education Rose Gerber, MS, discussed the recent Hill Day, what is being done about drug shortages, pharmacy benefit managers (PBMs), legislation that COA is supporting to protect patients and practices, and upcoming regulatory changes that could change the way cancer care is delivered. Rose and Nick also discussed the current status of CPAN, including the growth of new chapters and new engagement opportunities for CPAN members.

  • A Conversation About Cancer Survivorship

    June 21, 2023 12:00 pm

    Join the Community Oncology Alliance Patient Advocacy Network (CPAN) for a virtual Advocacy Chat on Wednesday, June 21 at noon ET.

  • Clinical Trials in the Community Oncology Setting: Positive Impact on Patient Care

    May 17, 2023 12:00 pm

    Colleen Lewis, MSN, ANP-BC, AOCNP

    Join COA’s Director of Patient Advocacy and Education Rose Gerber, MS, and Colleen Lewis, MSN, ANP-BC, AOCNP, Vice President, Nursing & Research Florida Cancer Specialists & Research Institute, will discuss Clinical Trials in the Community Oncology Setting and the positive impacts on patient care.

  • The Impact of Health Equity on Cancer Care

    April 12, 2023 12:00 pm

    Audrey Davis, LPC, PM-LPC

    Join COA’s Director of Patient Advocacy and Education Rose Gerber, MS, and Audrey Davis, LPC, PM-LPC, Director of Health Equity, Cancer Support Community, will discuss how patients are affected by various socioeconomic factors, what can be done to alleviate the negative impacts of these factors, and how organizations like COA and Cancer Support Community are working to increase health equity for all patients.

  • Evidence Based Nutrition for Cancer Patients and Survivors

    March 8, 2023 12:00 pm

    Jennifer Lafferty, MS, RD, CSO

    Rose Gerber, MS, COA’s Director of Patient Advocacy and Education, and special guest, Jennifer Lafferty, MS, RD, CSO, Clinical Oncology Nutritionist Supervisor, American Oncology Network (AON), to learn about the importance of evidence-based nutrition recommendation for cancer patients and survivors at all stages of the cancer care continuum. Jennifer will share her insight into how oncology nutrition benefits patients including better management of treatment symptoms, faster healing and recovery, improved treatment tolerance and more.